Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shyama Group is a diversified Indian enterprise with a significant presence in the pharmaceutical and healthcare sectors through its flagship division, Shyama Biotech. The company focuses on the manufacturing, marketing, and distribution of a wide array of pharmaceutical formulations, including tablets, capsules, liquids, and injectables. Their product portfolio spans multiple therapeutic categories such as anti-infectives, analgesics, gastroenterology, and nutritional supplements, aimed at providing high-quality and affordable healthcare solutions. In addition to its pharmaceutical operations, the group is involved in healthcare education and infrastructure development, strengthening the medical ecosystem in Northern India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shyama Group.